Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelotanserin in Chronic Primary Insomnia
NCT00452179Phase 2Completed
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nelotanserin in Insomnia (3 arms), sponsored by Arena Pharmaceuticals, Inc. Primary endpoint: Wake After Sleep Onset. Started Feb 2007; status: completed.
02
Drugs
nelotanserin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00452179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452179.